IP Library Granted Patent US 11,324,856
Granted Patent B2
US 11,324,856 · App. 16/296,465 · Granted May 10, 2022

Bone putty for bone pore and void filling

Inventors: Jeffrey Johnson (Flowood, MS); Nels Lauritzen (Somerville, NJ); Brent Mitchell (Haskell, NJ)
Assignee: ZAVATION MEDICAL PRODUCTS LLC
A61L27/3821A61L27/12A61L27/26A61L27/56A61L27/58A61L24/0084A61L27/10A61L27/3608A61L27/46A61L2300/414C07K14/78C08L67/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,324,856
App. No.
16/296,465
Granted
May 10, 2022
Kind
B2
Abstract

A bone pore or void filling composition is described. The composition includes a mixture of: a type I collagen and/or a type I collagen-glycosaminoglycan coprecipitate; a blend of polyethylene glycol polymers having different molecular weights; a bone growth stimulator; and bioactive glass. A kit for containing the bone pore or void filling composition, and methods for using the composition to fill a bone pore or void are also described.

Claims (23)

1. A bone pore or void filling composition, comprising a mixture of:

a collagen component comprising a type I collagen and/or a type I collagen-glycosaminoglycan coprecipitate;

a polyethylene glycol component comprising a blend of polyethylene glycol polymers having different molecular weights, wherein the blend of the polyethylene glycol polymers comprises 55% to 90% by weight of the composition;

a calcium phosphate component comprising tricalcium phosphate; and

a glass component comprising bioactive glass,

wherein the blend of polyethylene glycol polymers comprises a first polyethylene glycol polymer having a molecular weight within the range of 1350 g/mol to 1650 g/mol and a second polyethylene glycol polymer having a molecular weight within the range of 350 g/mol to 650 g/mol, the bioactive glass comprises from 3% to 7.5% by weight of the composition, the tricalcium phosphate comprises from 15% to 30% by weight of the composition, and the weight percent of the type I collagen or the type I collagen-glycosaminoglycan coprecipitate ranges from 0.2% to 1.5% relative to the total weight of the composition.

2. The composition of claim 1 , wherein the tricalcium phosphate and the bioactive glass in the mixture comprise particles dimensioned to fill the bone pores.

3. The composition of claim 1 , wherein the collagen component is milled through a screen mesh prior to including in the mixture.

4. The composition of claim 1 , wherein all components of the mixture are configured to fill bone pores of a size less than 600 microns.

5. The composition of claim 1 , wherein the bone pore filling composition comprises a type I collagen.

6. The composition of claim 1 , wherein the bone pore filling composition comprises a type I collagen-glycosaminoglycan coprecipitate.

7. The composition of claim 1 , wherein the composition further comprises a hemostatic agent.

8. A method of filling a bone pore or void, comprising administering a composition according to claim 1 to the site of the bone pore or void.

9. The method of claim 8 , wherein the composition is applied to the bone pore or void by an individual.

10. The method of claim 8 , wherein the composition is injected into the bone pore or void using a syringe.

11. The method of claim 8 , wherein the bone pore has a diameter from 75 microns to 350 microns.

12. The method of claim 8 , wherein the composition is applied to a bone pore in spongy bone.

13. The method of claim 8 , wherein the composition is applied to at least one of a natural bone void or a surgically created void.

14. A bone pore or void filling kit, comprising:

the bone pore or void filling composition of claim 1 ;

a syringe for administering the composition; and

a sterile package for holding the composition and the syringe.

15. The kit of claim 14 , further comprising instructions for filling a bone pore.

Assignments (2)
SECURITY INTEREST Recorded Jun 30, 2021
From: ZAVATION MEDICAL PRODUCTS, LLC; PAN MEDICAL US CORPORATION
To: VARAGON CAPITAL PARTNERS AGENT, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 056726/0881 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2020
From: JOHNSON, JEFFREY; LAURITZEN, NELS; MITCHELL, BRENT
To: ZAVATION MEDICAL PRODUCTS, LLC
Reel/Frame 054741/0060 →
Continuity (1)
Related Publication 20200282111A1 · Sep 10, 2020